1.
Absence of BRAF mutations in UV-protected mucosal melanomas
by Edwards, R H
Journal of medical genetics, 2004-04, Vol.41 (4), p.270-272

2.
Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG Repeat
by Rebbeck, Timothy R
American journal of human genetics, 1999, Vol.64 (5), p.1371-1377

3.
Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families
by LEVY-LAHAD, E
American journal of human genetics, 1997, Vol.60 (5), p.1059-1067

4.
High frequency of skewed X inactivation in young breast cancer patients
by Kristiansen, M
Journal of medical genetics, 2002-01, Vol.39 (1), p.30-33

5.
Array based CGH and FISH fail to confirm duplication of 8p22-p23.1 in association with Kabuki syndrome
by Hoffman, J D
Journal of medical genetics, 2005-01, Vol.42 (1), p.49-53

6.
Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?
by Martin, A-M
Journal of medical genetics, 2003-04, Vol.40 (4), p.e34-34

7.
Breast cancer genetics: What we know and what we need
by Nathanson, Katherine N
Nature medicine, 2001-05, Vol.7 (5), p.552-556

8.
Genetic heterogeneity in hereditary breast cancer : Role of BRCA1 and BRCA2
by REBBECK, T. R
American journal of human genetics, 1996, Vol.59 (3), p.547-553

9.
Germline CHEK21100delC mutations in breast cancer patients with multiple primary cancers
by Huang, J
Journal of medical genetics, 2004-11, Vol.41 (11), p.e120-e120

10.
Sex ratio skewing of offspring in families with hereditary susceptibility to breast cancer
by Domchek, S M
Journal of medical genetics, 2005-06, Vol.42 (6), p.511-513

11.
Kinetics of BRCA1 regulation in response to UVC radiation
by Clarkin, C E
Cellular and molecular life sciences : CMLS, 2000-07, Vol.57 (7), p.1126-1134

12.
Polymorphisms in PTEN in breast cancer families
by Carroll, Bryan T
Journal of medical genetics, 1999-02, Vol.36 (2), p.94-96

13.
Screening for Genomic Rearrangements in Families with Breast and Ovarian Cancer Identifies BRCA1 Mutations Previously Missed by Conformation-Sensitive Gel Electrophoresis or Sequen...
by Unger, Meredith A
American journal of human genetics, 2000, Vol.67 (4), p.841-850

14.
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study
by Domchek, Susan M
The lancet oncology, 2006, Vol.7 (3), p.223-229

15.
Factors Determining Dissemination of Results and Uptake of Genetic Testing in Families with Known BRCA1/2 Mutations
by Finlay, Esme
Genetic testing, 2008-03-01, Vol.12 (1), p.81-91

16.
Population Frequencies of Single Nucleotide Polymorphisms (SNPs) in Immuno-Modulatory Genes
by Martin, A.-M
Human heredity, 2003-01-01, Vol.55 (4), p.171-178

17.
An evaluation of two automated quality control methods designed for use with hourly wind profiler data
by MILLER, P. A
Annales geophysicae (1988), 1994, Vol.12 (8), p.711-724

18.
Transcript identification in the BRCA1 candidate region
by WEBER, B. L
Breast cancer research and treatment, 1995, Vol.33 (2), p.115-124

19.
BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis
by Chamberlain, J S
American journal of human genetics, 1993-04, Vol.52 (4), p.792-798

20.
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the cdk-inhibitor p21waf1/cip1
by SOMASUNDARAM, K
Nature (London), 1997, Vol.389 (6647), p.187-190
